Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

Clinical trial NCT06885697 · RECRUITING

Trial details

NCT number: NCT06885697
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Mesothelioma Neoplasms Stomach Neoplasms Pancreatic Neoplasms Ovarian Neoplasms Lung Neoplasms Thymus Neoplasms Colonic Neoplasms

Start date: 2025-07-08
Primary completion: 2034-06-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.